Literature DB >> 2787908

Calcitonin gene-related peptide (CGRP) in normotensive and spontaneously hypertensive rats.

D Xu1, X A Wang, J P Wang, Q X Yuan, R R Fiscus, J K Chang, J A Tang.   

Abstract

With the techniques of specific radioimmunoassay and gel filtration it was found that CGRP was distributed in various tissues of normotensive (WKY) and spontaneously hypertensive rats (SHR) with the highest concentration in the lumbar spinal cord (1197 +/- 94.8 pg/mg tissue) and the lowest in the auricle (15.0 +/- 2.1 pg/mg tissue). In comparison with WKY, CGRP concentration in the plasma was decreased and in the abdominal aorta and hypothalamus was increased in SHR. Gel filtration revealed only one major CGRP molecular form in the tissues. In addition, CGRP reduced the mean arterial pressure (MAP) in SHR in a dose-dependent manner. These data suggest that CGRP may play an important role in the pathogenesis of hypertension and its possible therapy.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2787908     DOI: 10.1016/0196-9781(89)90035-1

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  3 in total

1.  Calcitonin gene-related peptide inhibits chemokine production by human dermal microvascular endothelial cells.

Authors:  Jing Huang; Lori L Stohl; Xi Zhou; Wanhong Ding; Richard D Granstein
Journal:  Brain Behav Immun       Date:  2011-02-18       Impact factor: 7.217

Review 2.  Pathophysiology and therapeutic possibilities of calcitonin gene-related peptide in hypertension.

Authors:  I Márquez-Rodas; F Longo; R P Rothlin; G Balfagón
Journal:  J Physiol Biochem       Date:  2006-03       Impact factor: 5.080

3.  Circadian Variation in Vasoconstriction and Vasodilation Mediators and Baroreflex Sensitivity in Hypertensive Rats.

Authors:  Tamar Kezeli; Nikoloz Gongadze; Galina Sukoyan; Marina Shikhashvili; Zaza Chapichadze; Maia Okujava; Nino Dolidze
Journal:  J Circadian Rhythms       Date:  2019-10-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.